In this video, Jeremy Faust, MD, editor-in-chief of MedPage Today, discusses the U.S. patent system with Priti Krishtel, JD. Krishtel is the co-founder of I-MAK, a non-profit focused on building a more just and equitable medicines system in the U.S.

Krishtel reveals how the patent system rewards pharmaceutical companies that try to prevent competition and keep prescription drug prices artificially high.

The following is a transcript of their remarks:

Faust: Hello, this is Jeremy Faust, medical editor-in-chief of MedPage Today. Thank you for joining us.

We’re joined today by Priti Krishtel, a health justice lawyer. She’s the co-founder and co-executive director of I-MAK, Initiatives for Medicines, Access, and Knowledge. This is a non-profit that works on equitable medicines systems and patents and issues surrounding that. Priti Krishtel is also the recent recipient of the MacArthur Genius Award.

Well, thank you so much for joining us.

Krishtel: Thanks for having me.

Faust: Let’s dive into your work and what you do. Obviously COVID changed everything in terms of how I spend my time, and to some extent how you spend your time, I imagine. Can you […]